|
Feb 18, 14:50
|
Palantir upgraded, Workday downgraded: Wall Street's top analyst calls
|
N/A |
—
|
—
|
No analysis
|
|
Feb 18, 14:31
|
Is It Too Late to Chase Masimo Stock on Major Danaher News?
|
N/A |
—
|
—
|
No analysis
|
|
Feb 18, 14:09
|
How Recent Developments Are Reframing The Danaher (DHR) Investment Story
|
N/A |
—
|
—
|
No analysis
|
|
Feb 18, 13:50
|
Danaher’s $9.9B Masimo Deal Marks One of 2026’s Largest Medtech Buyouts
|
N/A |
—
|
—
|
No analysis
|
|
Feb 18, 11:19
|
Danaher Nears $10 Billion Masimo Deal, FT Reports
|
N/A |
—
|
—
|
No analysis
|
|
Feb 17, 18:00
|
Danaher acquires Masimo for $9.9bn to bolster diagnostics business
|
N/A |
—
|
—
|
No analysis
|
|
Feb 17, 16:29
|
Danaher Corp. (DHR) Signaled Signs of a Stable Bioprocessing Segment
|
N/A |
—
|
—
|
No analysis
|
|
Feb 17, 13:00
|
Possible Bearish Signals With Danaher Insiders Disposing Stock
|
N/A |
—
|
—
|
No analysis
|
|
Feb 17, 10:25
|
Danaher to buy Masimo for $9.9B to boost diagnostics portfolio
|
N/A |
—
|
—
|
No analysis
|
|
Feb 17, 09:41
|
Danaher shares are trading lower after the company announced it will acquire Masimo.
|
N/A |
—
|
—
|
No analysis
|
|
Feb 17, 09:05
|
Danaher To Acquire Masimo Corporation For $9.9B At $180/Share
|
N/A |
—
|
—
|
No analysis
|